BRCA1 and neoplasm: While tumor growth in Brca1-def models was monitored for 13 weeks post tumor-cell injection, Bard1-def models could only be monitored for 5 weeks due to the onset of cachexia, as described in our previous studies (Shakri et al, 2020).